D-0473-2025 Class II Ongoing

Recalled by Teva Pharmaceuticals USA, Inc — Parsippany, NJ

FDA drug recall D-0473-2025 was initiated by Teva Pharmaceuticals USA, Inc on May 23, 2025 and is designated Class II. Reason for recall: Presence of foreign tablets/capsules. The recall status is ongoing. Affected quantity: 36612 cartons.

Recall details

Product Type
Drugs
Report Date
Jul 2, 2025
Initiation Date
May 23, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
36612 cartons

Product description

Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.

Reason for recall

Presence of foreign tablets/capsules.

Distribution pattern

USA Nationwide

Code information

Lot#: 5420094, Exp 09/30/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0473-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0473-2025. Report a data issue: hello@regdatalab.com.